CDAKQ — Codiak BioSciences,. Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.06m
- -$26.01m
- $22.94m
Annual balance sheet for Codiak BioSciences,., fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 127 | 88.9 | 83.4 | 88.9 | 76.9 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 128 | 91.1 | 94.1 | 93.8 | 90.2 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 5.9 | 5.91 | 17.6 | 53.4 | 45.4 |
| Other Long Term Assets | |||||
| Total Assets | 134 | 97.7 | 116 | 151 | 172 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 3.89 | 4.89 | 19.8 | 17.7 | 27.2 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 4.93 | 5.63 | 94 | 137 | 118 |
| Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 129 | 92 | 22 | 14.6 | 53.5 |
| Total Liabilities & Shareholders' Equity | 134 | 97.7 | 116 | 151 | 172 |
| Total Common Shares Outstanding |